These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16877717)

  • 1. Is the fault in our steroids or in our selves?
    Schover LR
    J Clin Oncol; 2006 Aug; 24(22):3519-21. PubMed ID: 16877717
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic oophorectomy and hormone replacement therapy: protection at what price?
    Garber JE; Hartman AR
    J Clin Oncol; 2004 Mar; 22(6):978-80. PubMed ID: 14981100
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic oophorectomy in the genome age: balancing new data against uncertainties.
    Newman L
    J Natl Cancer Inst; 2001 Feb; 93(3):173-5. PubMed ID: 11158183
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues surrounding surgical menopause. Indications and procedures.
    Reich H
    J Reprod Med; 2001 Mar; 46(3 Suppl):297-306. PubMed ID: 11304878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
    Biglia N; Mariani L; Ponzone R; Sismondi P
    Maturitas; 2008 Jun; 60(2):71-7. PubMed ID: 18472232
    [No Abstract]   [Full Text] [Related]  

  • 7. Oophorectomy and cardiovascular mortality: is there a link?
    Parker WH; Manson JE
    Menopause; 2009; 16(1):1-2. PubMed ID: 18971791
    [No Abstract]   [Full Text] [Related]  

  • 8. Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health.
    Pacello PC; Yela DA; Rabelo S; Giraldo PC; Benetti-Pinto CL
    Climacteric; 2014 Aug; 17(4):342-7. PubMed ID: 24188246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing of estrogen therapy after ovariectomy--implications for neurocognitive function.
    Maki PM
    Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):494-5. PubMed ID: 18648334
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring success in ovarian cancer risk reducing strategies.
    Goodman A
    Cancer; 2011 Jun; 117(12):2588-9. PubMed ID: 21287539
    [No Abstract]   [Full Text] [Related]  

  • 11. Worsening of menopausal flushes after prophylactic oophorectomy.
    Poulose T; Ashelby L; Fox R
    J Obstet Gynaecol; 2006 Jul; 26(5):481-2. PubMed ID: 16846894
    [No Abstract]   [Full Text] [Related]  

  • 12. Routine ovary removal during hysterectomy ill-advised for most women.
    Harv Womens Health Watch; 2009 Jul; 16(11):7. PubMed ID: 19777675
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of ovarian cancer--let's do something.
    Westgren M
    Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1009-10. PubMed ID: 22708985
    [No Abstract]   [Full Text] [Related]  

  • 14. Elective oophorectomy. Benefits, risks of removing ovaries.
    Mayo Clin Womens Healthsource; 2006 Sep; 10(9):1-2. PubMed ID: 16909089
    [No Abstract]   [Full Text] [Related]  

  • 15. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
    Bresser PJ; Seynaeve C; Van Gool AR; Niermeijer MF; Duivenvoorden HJ; van Dooren S; van Geel AN; Menke-Pluijmers MB; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):95-103. PubMed ID: 17095208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to commentaries on retention of the ovaries and long-term survival after hysterectomy.
    Parker WH; Broder MS; Liu Z; Shoupe Z; Farquhar C; Berek JS
    Climacteric; 2006 Oct; 9(5):396-8; author reply 398-400. PubMed ID: 17000587
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies for ovarian cancer prevention.
    Dann RB; Kelley JL; Zorn KK
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Journey through the clinics - The experience of a woman with BRCA2.
    Abernethy K
    Post Reprod Health; 2015 Dec; 21(4):158-60. PubMed ID: 26612439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary ovarian cancer--assessing risk and prevention strategies.
    Pavelka JC; Li AJ; Karlan BY
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):651-65, vii-viii. PubMed ID: 18061862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen replacement after oophorectomy: comparison of patches and implants.
    Anderson CH; Raju SK; Forsling ML; Wheeler MJ
    BMJ; 1992 Jul; 305(6845):90-1. PubMed ID: 1449552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.